Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer.
Park LC, Lee HS, Shin SH, Park SJ, Park MI, Oh SY, Kwon HC, Baek JH, Choi YJ, Kang MJ, Kim YS.
Park LC, et al. Among authors: park mi, park sj.
World J Gastroenterol. 2012 Mar 14;18(10):1104-9. doi: 10.3748/wjg.v18.i10.1104.
World J Gastroenterol. 2012.
PMID: 22416186
Free PMC article.